Janus Kinase Inhibitors
DBCAT004108Pharmacologic class
Agents that inhibit JANUS KINASES. A DrugBank category of 9 drugs. 9 of them are approved.
What you can answer from here — as of November 29, 2022
Which targets do Janus Kinase Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account